T1	SNP 1068 1075	rs93886
T2	SNP 1111 1120	rs3785074
T3	SNP 1155 1164	rs4246742
T4	SNP 1199 1209	rs10069690
T5	SNP 1244 1253	rs2242652
T6	SNP 1292 1301	rs6990300
T7	Entity 1063 1067	TEP1
T8	Entity 1105 1110	TERF2
T9	Entity 1150 1154	TERT
T10	Entity 1194 1198	TERT
T11	Entity 1239 1243	TERT
T12	Entity 1287 1291	TNKS
T13	Entity 1383 1399	hormone receptor
T14	Entity 954 956	TL
T15	Entity 200 215	telomere length
T16	Entity 217 219	TL
R1	Equiv Arg1:T16 Arg2:T15	
R2	SNP_coupled_gene Arg1:T4 Arg2:T10	
R3	SNP_coupled_gene Arg1:T5 Arg2:T11	
R4	SNP_coupled_gene Arg1:T6 Arg2:T12	
T17	Association 1008 1019	association
E1	Association:T17 bc:T18 snp_int:T1 snp_int2:T24
R5	SNP_coupled_gene Arg1:T1 Arg2:T7	
R6	SNP_coupled_gene Arg1:T2 Arg2:T8	
R7	SNP_coupled_gene Arg1:T3 Arg2:T9	
T18	Cancer 1025 1038	breast cancer
T19	Entity 352 370	admixed population
T20	Entity 374 395;456 461	US non-Hispanic white women
T24	SNP 946 953;965 996	Several single nucleotide polymorphisms
R10	Member Arg1:T24 Arg2:T1	
R11	Member Arg1:T24 Arg2:T2	
R12	Member Arg1:T24 Arg2:T3	
R13	Member Arg1:T24 Arg2:T4	
R14	Member Arg1:T24 Arg2:T5	
R15	Member Arg1:T24 Arg2:T6	
T26	Entity 430 434;448 461	U.S. Mexican women
R18	Population_assignment Arg1:T24 Arg2:T19	
T21	Entity 430 443;456 461	U.S. Hispanic women
R8	Member Arg1:T19 Arg2:T20	
R9	Member Arg1:T19 Arg2:T26	
R16	Member Arg1:T19 Arg2:T21	
T25	Entity 605 621	TL-related genes
T27	Entity 636 640	MEN1
T28	Entity 642 648	MRE11A
T29	Entity 650 656	RECQL5
T30	Entity 658 662	TEP1
T31	Entity 664 668	TERC
T32	Entity 670 675	TERF2
T33	Entity 677 681	TERT
T34	Entity 683 687	TNKS
T35	Entity 693 698	TNKS2
R17	Member Arg1:T25 Arg2:T27	
R19	Member Arg1:T25 Arg2:T28	
R20	Member Arg1:T25 Arg2:T29	
R21	Member Arg1:T25 Arg2:T30	
R22	Member Arg1:T25 Arg2:T31	
R23	Member Arg1:T25 Arg2:T32	
R24	Member Arg1:T25 Arg2:T33	
R25	Member Arg1:T25 Arg2:T34	
R26	Member Arg1:T25 Arg2:T35	
T36	Organic_inorganic_molecules_affected 209 215	length
E3	Organic_inorganic_molecules_affected:T36 Theme:T14 Agent:T24
T37	Patho_physiology 1400 1416	status of tumors
E4	Patho_physiology:T37 Theme:T13 Agent:T24
T38	SNP 1459 1468	rs2736118
T39	Entity 1454 1458	TERT
R27	SNP_coupled_gene Arg1:T38 Arg2:T39	
T40	Association 1436 1448	associations
E5	Association:T40 snp_int:T38 bc:T42
T41	Level 1418 1430	Most notable
R28	Level_marker Arg1:E5 Arg2:T41	
A1	Level E5 High
T42	Cancer 1507 1564;1575 1581	estrogen receptor negative/progesterone receptor positive tumors
A2	Cancer_Type T42 Horm+ve_other
T43	Cancer 1566 1573;1575 1581	ER-/PR+ tumors
A3	Cancer_Type T43 Horm+ve_other
R29	Equiv Arg1:T43 Arg2:T42	
T44	SNP 1591 1600	rs2735940
T45	Entity 1586 1590	TERT
R30	SNP_coupled_gene Arg1:T44 Arg2:T45	
T46	Cancer 1638 1652	ER-/PR- tumors
A4	Cancer_Type T46 Horm-ve_other
E6	Association:T40 snp_int:T44 bc:T46
A5	Level E6 High
R31	Level_marker Arg1:E6 Arg2:T41	
T47	Organic_inorganic_molecules_affected 1436 1448	associations
E7	Organic_inorganic_molecules_affected:T47 Theme:T50 Agent:T38
E8	Organic_inorganic_molecules_affected:T47 Agent:T38 Theme:T48
T48	Entity 1507 1524	estrogen receptor
T49	Neg 1525 1533	negative
T50	Entity 1534 1555	progesterone receptor
T51	Effect_Type 1556 1564	positive
T52	Entity 1638 1640	ER
T53	Entity 1642 1644	PR
T54	Neg 1644 1645	-
T55	Neg 1640 1641	-
R32	Negation_marker Arg1:E8 Arg2:T49	
R33	Effect_type_marker Arg1:E7 Arg2:T51	
A6	Effect_Type E7 Increase
E9	Organic_inorganic_molecules_affected:T47 Agent:T44 Theme:T52 Theme2:T53
R34	Negation_marker Arg1:E9 Arg2:T55	
R35	SNP_location Arg1:T24 Arg2:T14	
R36	Equiv Arg1:T14 Arg2:T25	
